AAAP offers many committees within the organization for members to get involved and support the field and the Academy. Join today and make a difference! Please contact Lulu Malko if you are interested in joining one of the following committees:

Addiction and the Law

Laurence Westreich, MD, Chair, Elie Aoun, Co-Chair

The Law and Addiction Committee focuses on education and practice at the interface between addiction and the legal system. Some relevant issues include Drug Courts, the clinical treatment of addicted and dually diagnosed persons in the Justice System, employment law, child custody disputes, and Impaired Professional Assessments. The committee addresses educational gaps in the field, promotes collaboration between professionals and supports legislation and rules protective of the rights of people with addiction. The committee will also work in collaboration with the Public Policy committee.

Controversial Issues

Eric Collins, MD, Chair and Viral Goradia, MD, Co-Chair 

The Controversial Issues Committee arose several years ago out of the Chronic Pain Task Force that was under the auspices of the Treatment Section. Its mission is to use the principles and lessons of Addiction Psychiatry to help sort out proper medical practice in areas of uncertain and conflicting evidence.

CPD (Continuing Professional Development)  

Thomas Penders, MD Chair and Michael Goedde, MD Associate Chair

AAAP thinks that the continuing professional development (CPD) of our healthcare providers is extremely important. The CPD committee was formed because of the growing need for members to have access to educational resources that will be clinically useful to the field and to increase the likelihood that practitioners actually implement these treatments in their own practices and programs. This committee reviews what treatments work, how do we know they work and how can we put them into practice.

View Disclosures of our 2018 CPD Committee

Early Career

Sanchit Martui, MD, Chair

The Early Career Committee aims to offer mentoring and resources to Residents, Fellows and early career Attendings. This committee serves as a resource for providing guidance towards additional clinical training, research or career opportunities. It offers support for the transition from training to administrative and clinical leadership roles in a variety of practice settings.


Michael Hoefer, MD, Chair; Ramzi Mardam Bey, MD and Ellen Edens, MD, Co-Chairs 

The primary role of the Education Committee is to support high quality training for PGY I-V Addiction Psychiatry residents, promote the quality of teaching and clinical experience in the addictions in general psychiatry residency programs, and encourage medical students interested in the field of Addiction Psychiatry.

Cannabis Special Interest Group

Kevin Hill, MD, Chair

The cannabis special interest group aims to inform both treatment of cannabis addiction and cannabis-related policies from an evidence-based perspective. Members share our clinical experiences treating cannabis addiction as well as the challenges and concerns we have about the changing landscape of marijuana cannabis policy as state after state faces questions about medical cannabis and legalization of cannabis.


Jose Vito, MD, Chair; Grace Hennessy, MD Co-Chair and Jose Feliberti, MD, Trainee Co-chair

The Membership Committee strives to anticipate, ascertain and address the needs and wishes of its membership. The Membership Commit­tee asserts that members are the organization’s most important asset and through constant dialogue, works to continue to improve member benefits and experience. The Membership Committee welcomes members at all levels of their career who would like to become involved.

Physician Health

John Fromson, MD, Chair

The Physician Health committee serves as an educational and policy planning resource for clinical, administrative and research issues related to the identification and treatment of physicians with psychoactive substance use or other psychiatric disorders as well as factors relating to the prevention of such illnesses.

Public Policy

Richard N. Rosenthal, MD, Section Head Chair; Hilary S. Connery, MD, PhD, Co-Chair and Justine Welsh, MD, Early Career Co-Chair

The Public Policy Committee assists with the generation, coordination and dissemination of AAAP policy recommendations regarding addictive disorders to the general public. The Public Policy Section works in close collaboration with the Research, Treatment and Education Sections of AAAP to promote excellence of clinical practice in Addiction Psychiatry, to educate the public regarding substance use disorders, to promote accessibility and quality of treatment for all patients, and to support research in the field. Further, the Public Policy Section supports the Board of Directors in their deliberations regarding AAAP positions on legal cases and legislative initiatives pertinent to substance use disorders and addiction psychiatry.


Kevin Gray MD, Chair and Edward Thomas Lewis III, MD, Co-Chair

The Research Section examines how recent research advances inform the contemporary practice of Addiction Psychiatry. A particular interest is determining how scientific discoveries are translated into real-world clinical practice by AAAP members and how best to ensure that the most relevant research findings are transmitted to the membership in a timely fashion to promote life-long learning.

Scientific Program Committee (SPC)

Carol Weiss, MD, Chair; Nitigna Desai, MD Co-Chair, and Elie Aoun, MD, Associate Chair

AAAP’s Scientific Program Committee (SPC) reviews and selects all scientific content and plans the AAAP Annual Meeting. The SPC is an active and integral component of AAAP; each committee member significantly contributes to the quality and planning of the Annual Meeting and Scientific Symposium by reviewing and selecting submissions for symposia, papers, posters, concurrent workshop sessions, and other meeting programming.

This CME activity has been developed by AAAP’s Scientific Committee that meets once a month to plan and develop the educational sessions presented during this event. Disclosure information for each committee member is collected annually and is managed and/or resolved accordingly.

Sexual and Gender Diversity (LGBTQ+) Special Interest Group

Brian Hurley, MD, Chair

The Gender and Sexuality Special Interest Group supports educational programming at the intersection of addiction psychiatry, gender, and sexuality. The group advocates for policies that support equality in a world with broad gender and sexual diversity, and fosters social and professional community-building. AAAP members who may identify as LGTBQ+ and/or any other identity along the gender identity, gender expression, sexuality, and sex developmental spectra are welcome to join. This Special Interest Group supports AAAP’s partnership with the many health associations that address sexual and gender diversity.

Twelve-Step Recovery

Marc Galanter, MD, Chair

The purpose of this committee is to (1) clarify the state of research on the mode of operation of Twelve-Step programs; (2) promote clinically-related approaches, such as the dissemination of Twelve-Step facilitation to enhance psychiatrists’ ability to refer patients to such programs effectively; and (3) consider means by which psychiatric residents and fellows can best be given training on these issue.

Women in Addiction Psychiatry Special Interest Group

Amy Yule, MD and Dana Sarvey, MD, Co-chairs; Natassia Gaznick, MD, Trainee Co-Chair

The purpose of the group is to provide a forum for networking and mentoring for women in the field of addiction psychiatry. The group will also serve as an educational and policy planning resource for addiction related issues specific to women. The group welcomes and encourages women in all stages of their career, as well as from various cultural and ethnic backgrounds, and from different geographical regions, to join. Trainees are also encouraged to join.

Youth and Adolescence

David Atkinson MD, Chair and Martha Ignaszewski, MD, Trainee Co-Chair

The Child and Youth Treatment Committee seeks to identify and address issues unique to our youngest patients. The committee promotes the visibility of addiction treatment of minors by presenting symposia and workshops about child and adolescent substance abuse and distributing educational materials to a broader audience.